These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 23022425)

  • 1. Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis.
    Iavarone M; Manini MA; Sangiovanni A; Fraquelli M; Forzenigo LV; Di Tommaso L; Aghemo A; Roncalli M; Ronchi G; Colombo M
    Dig Liver Dis; 2013 Jan; 45(1):43-9. PubMed ID: 23022425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Dig Liver Dis; 2015 Sep; 47(9):775-82. PubMed ID: 26043653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
    Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
    Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
    Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
    Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
    Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
    Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplastic nodules in liver cirrhosis: detection with triple phase helical dynamic CT.
    Lim JH; Kim MJ; Park CK; Kang SS; Lee WJ; Lim HK
    Br J Radiol; 2004 Nov; 77(923):911-6. PubMed ID: 15507413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dysplastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound.
    Giorgio A; Calisti G; di Sarno A; Farella N; de Stefano G; Scognamiglio U; Giorgio V
    Anticancer Res; 2011 Nov; 31(11):3977-82. PubMed ID: 22110230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysplastic hepatic nodules: radiological abnormalities and histopathological correlations.
    Ouedraogo NA; Danjoux-de-Volontat M; Auriol J; Peron JM; Rousseau H; Otal P
    Eur J Radiol; 2011 Aug; 79(2):232-6. PubMed ID: 20675086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
    Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease.
    O'Malley ME; Takayama Y; Sherman M
    Am J Gastroenterol; 2005 Jul; 100(7):1523-8. PubMed ID: 15984975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonography-guided percutaneous microwave ablation of high-grade dysplastic nodules in cirrhotic liver.
    Liang P; Dong B; Yu X; Wang Y; Sheng L; Yu D; Xiao Q
    AJR Am J Roentgenol; 2005 May; 184(5):1657-60. PubMed ID: 15855134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma.
    Caturelli E; Bartolucci F; Biasini E; Vigliotti ML; Andriulli A; Siena DA; Attino V; Bisceglia M
    Am J Gastroenterol; 2002 Feb; 97(2):397-405. PubMed ID: 11866279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
    Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
    Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study.
    Sato T; Kondo F; Ebara M; Sugiura N; Okabe S; Sunaga M; Yoshikawa M; Suzuki E; Ogasawara S; Shinozaki Y; Ooka Y; Chiba T; Kanai F; Kishimoto T; Nakatani Y; Fukusato T; Yokosuka O
    Hepatol Int; 2015 Apr; 9(2):330-6. PubMed ID: 25788204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis.
    Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2006 Feb; 106(3):636-47. PubMed ID: 16369988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development.
    Borzio M; Fargion S; Borzio F; Fracanzani AL; Croce AM; Stroffolini T; Oldani S; Cotichini R; Roncalli M
    J Hepatol; 2003 Aug; 39(2):208-14. PubMed ID: 12873817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysplastic nodules in cirrhotic liver: arterial phase enhancement at CT and MR imaging--a case report.
    Krinsky GA; Theise ND; Rofsky NM; Mizrachi H; Tepperman LW; Weinreb JC
    Radiology; 1998 Nov; 209(2):461-4. PubMed ID: 9807574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.